20.11.2012 • NewsEnergyGasgas industry

LNG Could Be Exempt from Gazprom Export Monopoly

An exception to Gazprom's monopoly on Russia's gas exports could in theory be made for exports of seaborne liquefied natural gas (LNG), Russia's energy minister said on Tuesday.

"In theory there are possible options specifically for LNG," Alexander Novak told reporters. "What form to use and what system of agreements with Gazprom Export and others - it would need to be developed specifically."

Gazprom's monopoly is protected by law. But Russia's top non-state gas producer, Novatek, appears to be in the lead in the development of new LNG facilities with its Yamal LNG project, which has France's Total as a 20% shareholder.

The Kremlin, concerned about declining markets in Europe, a key source of revenues for Gazprom and therefore for the Russian budget, wants to shift Russia's gas strategy toward LNG, in particular for the growing Asian market.

President Vladimir Putin told Novatek CEO Leonid Mikhelson on Monday, however, that he must work with Gazprom to sell Yamal LNG's output, suggesting he is loath to sacrifice Gazprom's export monopoly to get a much desired LNG strategy off the ground.

Putin noted Novatek would need export contracts to secure financing for the project.

Novak did not comment on Putin's remarks, nor did he specify whether the law would require amendments in order for Novatek to ship LNG independently.

He said the ministry would rule by the end of the year on whether Novatek, which has requested rights to handle its own exports from its Yamal LNG project, can export LNG independently of Gazprom.

 

Innovation Pitch

The Start-up Platform for Chemistry & Life Sciences
Discover Tomorrow’s Innovators

The Start-up Platform for Chemistry & Life Sciences

CHEManager Innovation Pitch supports innovation in the chemistry and life sciences start-up scene. The platform allows founders, young entrepreneurs, and start-ups to present their companies to the industry.

Virtual Event

Digitalization in the Chemical Industry
CHEManager Spotlight

Digitalization in the Chemical Industry

Save the Date: October 22, 2025
The event will be promoted to a combined audience of over 100,000 professionals across Europe through the CHEManager and CITplus networks.

most read

Photo
06.03.2025 • News

CordenPharma Expands Peptide Manufacturing Platform in Switzerland

Contract development and manufacturing organization (CDMO) CordenPharma has finalized plans to establish a new peptide manufacturing facility in Switzerland located at Getec Park in Muttenz near Basel. This investment is part of the company’s growth initiatives with a more than €1 billion strategic investment in peptide development and manufacturing.

Photo
21.03.2025 • News

What’s Next for Pharma Supply Chains?

Sudden shifts in demand, supply shortages and global collapse have put immense pressure on pharmaceutical logistics. To address these challenges, PHARMAP 2025 brings together industry experts to discover AI-driven supply chain optimisation, strategic logistics partnerships and digital solutions that enhance efficiency and resilience in the pharmaceutical supply chain.